Evidence map›Paper›PMID 27109256›Full record

ReviewAddiction (Abingdon, England)2017

A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products.

David T Levy, K Michael Cummings, Andrea C Villanti, Ray Niaura, David B Abrams, Geoffrey T Fong, Ron Borland

Erratum issuedAbstract readReview
In one paragraph

Review in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 104 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Overview of Electronic Nicotine Delivery Systems: A Systematic Review.American journal of preventive medicine · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Recent Trends in Cigarette and HTP Use in Japan: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model.Canadian journal of public health = Revue canadienne de sante publique · 2023
    Article
  19. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  20. Do Tobacco Companies Have an Incentive to Promote "Harm Reduction" Products?: The Role of Competition.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

David T LevyDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Andrea C VillantiThe Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative, Washington, DC, USA.
Ray NiauraDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
David B AbramsDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, Ontario, Canada.
Ron BorlandNigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Victoria, Australia.

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FONG, GEOFFREY T · 2016 to 2025
$25.3M
MODELING THE POLICY IMPACT OF CIGARETTE AND SMOKELESS USE ON US MORTALITYR01DA036497 · NIDA · GEORGETOWN UNIVERSITY · PI LEVY, DAVID THEODORE · 2013 to 2016
$2.5M
NCI NIH HHS P01 CA200512NIDA NIH HHS R01 DA036497
6 · The paper itself

Abstract

The use of vaporized nicotine products (VNPs), especially e-cigarettes and, to a lesser extent, pressurized aerosol nicotine products and heat-not-burn tobacco products, are being adopted increasingly as an alternative to smoking combusted products, primarily cigarettes. Considerable controversy has accompanied their marketing and use. We propose a framework that describes and incorporates patterns of VNP and combustible cigarette use in determining the total amount of toxic exposure effects on population health. We begin by considering toxicity and the outcomes relevant to population health. We then present the framework and define different measures of VNP use; namely, trial and long-term use for exclusive cigarette smokers, exclusive VNP and dual (cigarette and VNP) use. Using a systems thinking framework and decision theory we considered potential pathways for current, former and never users of VNPs. We then consider the evidence to date and the probable impacts of VNP use on public health, the potential effects of different policy approaches and the possible influence of the tobacco industry on VNP and cigarette use.

Indexed as

Electronic Nicotine Delivery SystemsHumansNebulizers and VaporizersPublic HealthSmoking CessationTobacco IndustryUnited StatesE-cigarettesframeworkharm reductionindustry responsepublic healthpublic policy

Identifiers

PMID27109256
PMCPMC5079857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.